Cargando…

Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture

The angucyclines form the largest family of polycyclic aromatic polyketides, and have been studied extensively. Herein, we report the discovery of lugdunomycin, an angucycline‐derived polyketide, produced by Streptomyces species QL37. Lugdunomycin has unique structural characteristics, including a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Changsheng, van der Heul, Helga U., Melnik, Alexey V., Lübben, Jens, Dorrestein, Pieter C., Minnaard, Adriaan J., Choi, Young Hae, van Wezel, Gilles P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519343/
https://www.ncbi.nlm.nih.gov/pubmed/30656821
http://dx.doi.org/10.1002/anie.201814581
_version_ 1783418623487901696
author Wu, Changsheng
van der Heul, Helga U.
Melnik, Alexey V.
Lübben, Jens
Dorrestein, Pieter C.
Minnaard, Adriaan J.
Choi, Young Hae
van Wezel, Gilles P.
author_facet Wu, Changsheng
van der Heul, Helga U.
Melnik, Alexey V.
Lübben, Jens
Dorrestein, Pieter C.
Minnaard, Adriaan J.
Choi, Young Hae
van Wezel, Gilles P.
author_sort Wu, Changsheng
collection PubMed
description The angucyclines form the largest family of polycyclic aromatic polyketides, and have been studied extensively. Herein, we report the discovery of lugdunomycin, an angucycline‐derived polyketide, produced by Streptomyces species QL37. Lugdunomycin has unique structural characteristics, including a heptacyclic ring system, a spiroatom, two all‐carbon stereocenters, and a benzaza‐[4,3,3]propellane motif. Considering the structural novelty, we propose that lugdunomycin represents a novel subclass of aromatic polyketides. Metabolomics, combined with MS‐based molecular networking analysis of Streptomyces sp. QL37, elucidated 24 other rearranged and non‐rearranged angucyclines, 11 of which were previously undescribed. A biosynthetic route for the lugdunomycin and limamycins is also proposed. This work demonstrates that revisiting well‐known compound families and their producer strains still is a promising approach for drug discovery.
format Online
Article
Text
id pubmed-6519343
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65193432019-05-23 Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture Wu, Changsheng van der Heul, Helga U. Melnik, Alexey V. Lübben, Jens Dorrestein, Pieter C. Minnaard, Adriaan J. Choi, Young Hae van Wezel, Gilles P. Angew Chem Int Ed Engl Communications The angucyclines form the largest family of polycyclic aromatic polyketides, and have been studied extensively. Herein, we report the discovery of lugdunomycin, an angucycline‐derived polyketide, produced by Streptomyces species QL37. Lugdunomycin has unique structural characteristics, including a heptacyclic ring system, a spiroatom, two all‐carbon stereocenters, and a benzaza‐[4,3,3]propellane motif. Considering the structural novelty, we propose that lugdunomycin represents a novel subclass of aromatic polyketides. Metabolomics, combined with MS‐based molecular networking analysis of Streptomyces sp. QL37, elucidated 24 other rearranged and non‐rearranged angucyclines, 11 of which were previously undescribed. A biosynthetic route for the lugdunomycin and limamycins is also proposed. This work demonstrates that revisiting well‐known compound families and their producer strains still is a promising approach for drug discovery. John Wiley and Sons Inc. 2019-01-29 2019-02-25 /pmc/articles/PMC6519343/ /pubmed/30656821 http://dx.doi.org/10.1002/anie.201814581 Text en © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Communications
Wu, Changsheng
van der Heul, Helga U.
Melnik, Alexey V.
Lübben, Jens
Dorrestein, Pieter C.
Minnaard, Adriaan J.
Choi, Young Hae
van Wezel, Gilles P.
Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture
title Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture
title_full Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture
title_fullStr Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture
title_full_unstemmed Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture
title_short Lugdunomycin, an Angucycline‐Derived Molecule with Unprecedented Chemical Architecture
title_sort lugdunomycin, an angucycline‐derived molecule with unprecedented chemical architecture
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519343/
https://www.ncbi.nlm.nih.gov/pubmed/30656821
http://dx.doi.org/10.1002/anie.201814581
work_keys_str_mv AT wuchangsheng lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture
AT vanderheulhelgau lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture
AT melnikalexeyv lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture
AT lubbenjens lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture
AT dorresteinpieterc lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture
AT minnaardadriaanj lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture
AT choiyounghae lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture
AT vanwezelgillesp lugdunomycinanangucyclinederivedmoleculewithunprecedentedchemicalarchitecture